Hasten Biopharma Acquires Commercial Rights in China for Roc

/PRNewswire/ -- Hasten Biopharmaceutic Co., Ltd (China) ("Hasten") today announced that it has acquired the commercial rights in China for Rocephin®, a...

Related Keywords

Shanghai , China , Switzerland , Hefei , Anhui , Singapore , Swiss , , Prnewswire Hasten Biopharmaceutic Co Ltd China , Hefei Industry Investment Group , Group Is Asia , Hasten Biopharmaceutic Co Ltd , Linkedin , Emergency Room , Intensive Care Unit , Hasten Biopharma , Feidong County , Cbc Group ,